Chika Anekwe | Preventive Medicine | Best Researcher Award

Published on by Academic Awards

Dr. Chika Anekwe | Preventive Medicine | Best Researcher Award

Dr. Chika Anekwe, Massachusetts General Hospital,United States

Dr. Chika Anekwe is a distinguished physician and public health advocate with expertise in obesity medicine. 🩺 She holds an MD from the University of Connecticut and an MPH from Columbia University. Currently an Assistant Physician at Massachusetts General Hospital, she previously served at SUNY Stony Brook and Harvard Medical School. Dr. Anekwe’s research focuses on innovative obesity treatments, earning her recognition such as the Biodiversity Fellows Leadership Development Program. She’s also the founder of the New England Obesity Society and contributes as a medical reviewer for Very Well Health. 🏅📚

 

Publication Profile:

Google Scholar

Education:

Dr. Chika Anekwe pursued a diverse academic journey, earning an AB in Molecular Biology from Princeton University in 2006, followed by an MD in Medicine from the University of Connecticut in 2011. 🎓 Her thirst for knowledge led her to attain a Master of Public Health (MPH) degree from Columbia University in 2014, rounding out her expertise in healthcare and public health. 🏥 Throughout her educational endeavors, Dr. Anekwe demonstrated a commitment to understanding the intricate intersections of biology, medicine, and public health, laying the foundation for her impactful career in the healthcare sector.

Honors and Prizes:

Dr. Chika Anekwe’s dedication and achievements have garnered her prestigious honors and prizes throughout her career. 🏆 As a Jackie Robinson Foundation Scholar from 2002 to 2006, she exemplified academic excellence. She continued to excel as an Extra Innings Fellow from 2007 to 2011, supported by the Jackie Robinson Foundation. Additionally, she was recognized as a Sylvia Parkinson Scholar in 2010 by The Hartford Foundation for Public Giving. Her commitment to leadership and innovation was further acknowledged through her participation in the Biodiversity Fellows Leadership Development Program in 2018-2019. Recently, she was named a finalist for the MGH Department of Medicine Diversity and Inclusion Board Sanchez and Ferguson Research Faculty Award in 2021. 🌟

Teaching and Training:

Dr. Chika Anekwe’s commitment to education shines through her involvement in teaching and training programs. 📚 At SUNY Stony Brook Medical Center, she taught Foundations of Medical Practice to 1st and 2nd-year students, offering bi-weekly sessions over three semesters. Transitioning to HMS, she conducted clinical sessions on Metabolism, Nutrition, and Lifestyle Medicine for 3rd and 4th-year students. 🍏 In 2021, she engaged 1st-year HMS students in discussions on Health Policy during bi-weekly sessions. Her dedication continued with the creation of Advanced Integrated Science Course (AISC) sessions focusing on Nutrition, Obesity, and Equity for 3rd-year HMS students in 2023. 🏥

Research Focus:

Dr. Chika Anekwe’s research focuses primarily on the multifaceted aspects of obesity, spanning socioeconomics, pharmacotherapy, and healthcare delivery. 📊 Her work delves into understanding the socioeconomic factors influencing obesity prevalence and management, as well as exploring pharmacotherapeutic options and their effects on metabolic health. Additionally, she investigates the impact of bariatric surgery on diabetes management and compliance. Through her diverse studies, Dr. Anekwe contributes significantly to advancing our understanding of obesity-related conditions and their management, aiming to improve healthcare outcomes and quality of life for individuals affected by obesity. 🏥

Publication Top Notes:
  1. Socioeconomics of obesity📊 Published in Current obesity reports in 2020, cited by 102.
  2. Weight regulation in menopause🩸 Published in Menopause (New York, NY) in 2021, cited by 24.
  3. Ketogenic diet-induced elevated cholesterol, elevated liver enzymes and potential non-alcoholic fatty liver disease🥩 Published in Cureus in 2020, cited by 24.
  4. The role of bariatric surgery on diabetes and diabetic care compliance🩹 Published in Current diabetes reports in 2019, cited by 13.
  5. Pleural pressure targeted positive airway pressure improves cardiopulmonary function in spontaneously breathing patients with obesity🫁 Published in Chest in 2021, cited by 12.
  6. Pharmacotherapeutic options for weight regain after bariatric surgery💊 Published in Current Treatment Options in Gastroenterology in 2021, cited by 8.
  7. A Women’s health perspective on managing obesity🚺 Published in Progress in Cardiovascular Diseases in 2023, cited by 3.
  8. Pharmacotherapy causing weight gain and metabolic alteration in those with obesity and obesity‐related conditions: A review📑 Published in Annals of the New York Academy of Sciences, year of publication unspecified.
  9. Epidemiology of obesity among people with HIV🩺 Published in Current Opinion in HIV and AIDS in 2024, year of publication unspecified.
  10. Role of Reimbursement in the Delivery of Treatment for Obesity in Adults and Children💰 Published in Handbook of Obesity-Volume 2 in 2023, year of publication unspecified.

Erica Pietroluongo | Medicine | Young Scientist Award

Published on by Academic Awards

Dr. Erica Pietroluongo | Medicine | Young Scientist Award

Dr. Erica Pietroluongo, University of Naples Federico II, Italy

👩‍⚕️ Dr. Erica Pietroluongo is a dedicated oncologist and researcher based in Naples, Italy. With an MD from the University of Naples Federico II and ongoing PhD studies in Advanced Biomedical and Surgical Therapies, she specializes in medical oncology, particularly in rare tumors. Dr. Pietroluongo is actively involved in various professional societies, including the American Society of Clinical Oncology and the International Thymic Malignancy Working Group. Her research focuses on improving treatment personalization in breast cancer and investigating bioumoral determinants in SARS-Cov-2-infected patients with thymic epithelial tumors. She also contributes to teaching and training future medical professionals.

Publication Profile:

Scopus

Orcid

Education:

📚 Dr. Erica Pietroluongo pursued her passion for medicine at the University of Naples Federico II, where she earned her MD in Medicine. With a strong foundation in healthcare, she embarked on a journey of continuous learning, currently immersing herself in the realm of research as a PhD student in Advanced Biomedical and Surgical Therapies. Under the guidance of Prof. F Pane at the Department of Clinical Medicine and Surgery, University of Naples Federico II, she delves into cutting-edge studies. 🎓 Committed to advancing medical knowledge, Dr. Pietroluongo’s dual roles as a physician and researcher epitomize her dedication to enhancing patient care and outcomes.

Teaching and Training:

📝 Dr. Erica Pietroluongo is deeply committed to advancing her skills in clinical research and teaching methodologies. In April 2023, she participated in a Medical Writing Course organized by the Italian Society of Surgery in Campobasso, in collaboration with prestigious institutions like Springer Nature and the University of Naples Federico II. This course equipped her with essential writing skills vital for disseminating research findings effectively. Moreover, in June 2023, she further honed her expertise as an “Expert in Evaluation and Facilitation of Regional Oncology Networks” through a program facilitated by AGENAS, the National Agency for Health Regional Services. 🌟 These training initiatives underscore Dr. Pietroluongo’s commitment to enhancing her capabilities and contributing to the advancement of healthcare practices.

Research Focus:

🔍 Dr. Erica Pietroluongo’s research focus primarily revolves around two key areas: thymic epithelial tumors and breast cancer. In her studies on thymic epithelial tumors, she explores the impact of SARS-Cov-2 mRNA vaccines on patients’ immune responses and seroconversion. Additionally, she investigates the potential diagnostic role of miRNAs in breast cancer, particularly miRNA-27a and miRNA-128, packaged in extracellular vesicles. Her work not only sheds light on the immunological responses to COVID-19 vaccines in cancer patients but also aims to identify novel biomarkers for improved diagnosis and prognosis in breast cancer. Dr. Pietroluongo’s research contributes significantly to both oncology and immunology fields. 🎯

Publication Top Notes:

Serum biomarkers of inflammation and vascular damage upon SARS-Cov-2 mRNA vaccine in patients with thymic epithelial tumors

miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer

Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors